Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02110498 · ClinicalTrials.gov registry record
Early Detection of Pancreatic Cystic Neoplasms
A clinical trial of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT02110498: Completed study of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts, sponsored by Johns Hopkins University.
NCT02110498 is a study of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts that has completed, run by Johns Hopkins University. The registered enrollment target is 3,000 participants, above the 1,531-participant average among 4 other Intraductal Papillary Mucinous Neoplasm trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02110498, a study of Intraductal Papillary Mucinous Neoplasm and Pancreatic Cysts, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to learn more about pancreatic cysts. The tests that are currently available are imperfect at determining exactly what type of pancreatic cyst a person has, which cysts contain cancer, or what the risk is of developing cancer in the future. The aim of this study is to use a combination of clinical, imaging, cyst fluid analysis, and molecular markers to try to help develop better tools to answer these questions.
Conditions Studied
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2014-03 |
| Est. Completion | 2025-03 |
What the finished NCT02110498 record still lists
NCT02110498 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 1,531-participant average among 4 other Intraductal Papillary Mucinous Neoplasm trials with a reported enrollment target (96% higher).
The record links to 5 conditions, with Intraductal Papillary Mucinous Neoplasm appearing as the primary indexed condition, and to 0 interventions.
NCT02110498 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02110498 about?
NCT02110498 is a clinical study titled "Early Detection of Pancreatic Cystic Neoplasms". This research is being done to learn more about pancreatic cysts. The tests that are currently available are imperfect at determining exactly what type of pancreatic cyst a person has, which cysts contain cancer, or what the risk is of developing cancer in the future. The aim of this study is to use...
What is the current status of trial NCT02110498?
This trial is currently completed. The enrollment target is 3,000 participants. The study started on 2014-03. Estimated completion is 2025-03.
What conditions does trial NCT02110498 study?
This clinical trial studies the following conditions: Intraductal Papillary Mucinous Neoplasm, Pancreatic Cysts, Pancreatic Mucinous Cystic Neoplasm, Cystic, Mucinous and/or Serous Neoplasm, Solid Pseudopapillary Tumour of the Pancreas.
Who is sponsoring clinical trial NCT02110498?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02110498 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraductal Papillary Mucinous Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia